Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Association of Alk1 and Endoglin Polymorphisms with Cardiovascular Damage.

Scientific reports - 10 Jun 2020

Garzon-Martinez Mercedes, Perretta-Tejedor Nuria, Garcia-Ortiz Luis, Gomez-Marcos Manuel A, Gonzalez-Sarmiento Rogelio, Lopez-Hernandez Francisco J, Martinez-Salgado Carlos

Abstract excerpt

Cardiovascular diseases are associated to risk factors as obesity, hypertension and diabetes. The transforming growth factor-β1 receptors ALK1 and endoglin regulate blood pressure and vascular homeostasis. However, no studies relate the association of ALK1 and endoglin polymorphisms with cardiovascular risk factors. We analysed the predictive value of the ALK1 and endoglin polymorphisms on cardiovascular target...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Activin Receptors, Type II
Share to Anaplastic Lymphoma Kinase

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Diabetes Mellitus

Share to Endoglin

Share to Heart Rate

Share to Hypertension

Share to Predictive Value of Tests

Share to Transforming Growth Factor beta1

Source

Open in PubMed Open full text

Identifiers

PMID: 32523017
DOI: 10.1038/s41598-020-66238-9
PMCID: PMC7287057

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Association of Alk1 and Endoglin Polymorphisms with Cardiovascular Damage.PMID 32523017Read ↗

Pathological Implications of Receptor for Advanced Glycation End-Product (AGER) Gene PolymorphismSemantic proximity Read ↗

Endoglin pathway genetic variation in preeclampsia: A validation study in Norwegian and Latina cohorts.Semantic proximity Read ↗

A meta-analysis of receptor for advanced glycation end products gene: four well-evaluated polymorphisms with diabetes mellitus.Semantic proximity Read ↗

Endoglin: a critical mediator of cardiovascular healthSemantic proximity Read ↗

Association of glycated hemoglobin A1c levels with cardiovascular outcomes in the general population: Results from the BiomarCaRE (Biomarker for Cardiovascular Risk Assessment in Europe) consortiumSemantic proximity Read ↗

Common polymorphisms in the glyoxalase-1 gene and their association with pro-thrombotic factors.Semantic proximity Read ↗

Functional analysis of the common haplotype in the receptor for advanced glycation end-products gene previously identified as a susceptibility factor for diabetic nephropathy.Semantic proximity Read ↗

Fructosamine 3-kinase and glyoxalase I polymorphisms and their association with soluble RAGE and adhesion molecules in diabetes.Semantic proximity Read ↗

Polymorphisms in glyoxalase 1 gene are not associated with vascular complications: the Hoorn and CoDAM studies.Semantic proximity Read ↗

-374 T/A polymorphism in RAGE gene is associated with onset of diabetes mellitus, atherosclerosis, and renal dysfunction in patients with hypertension.Semantic proximity Read ↗

Receptor for advanced glycation end products polymorphisms in coronary artery ectasia.Semantic proximity Read ↗

Genetic variants in ICAM1, PPARGC1A and MTHFR are potentially associated with different phenotypes of diabetic retinopathy.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.